Fit and well (finding)
D0001 Swine Flu (Novel Influenza A H1N1) Vaccine Study
Year Started: 2009
Two new vaccines (Baxter swine flu & GSK swine flu vaccine) have been made against swine flu in response to the pandemic. These vaccines have been tested in adults, but there is less information on how well they work in children. This study will assess these two new vaccines in children aged between six months and twelve years
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Tonsillitis (disorder)
D0004 Deposit of tonsils, adenoids and additional samples
Year Started: 2009
Children going for adenotonsillectomy, tonsillectomy or adenoidectomy will be approached to donate samples. Additional samples to be collected at this time may include saliva samples, urine samples, a blood sample and a nasal swab
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Saliva | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Saliva | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Chronic multifocal osteomyelitis (disorder)
D0005 Chronic Recurrent Multi focal Osteomyelitis
Year Started: 2013
Donors will be identified as satisfying the diagnostic criteria for Chronic Recurrent Multifocal Osteomyelitis through clinical consultations.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
RNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0008 Multi-centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Baxter H1N1 vaccine and GlaxoSmithKline H1N1 vaccine in children 6 months to 12 years of age
Year Started: 2009
D0008 Multi-centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Baxter H1N1 vaccine and GlaxoSmithKline H1N1 vaccine in children 6 months to 12 years of age
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0009 Study to evaluate the induction of immune memory following infant vaccination with a glycol-conjugate Neisseria Meningitidis serogroup C Vaccine
Year Started: 2011
Please note, this collection consists of blood clots but it is listed as plasma. Study to evaluate the induction of immune memory following infant vaccination with a glycol-conjugate Neisseria Meningitidis serogroup C Vaccine and to assess the immune response to the concurrent infant routine immunisations administered in consistent versus alternating limbs.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0010 Comparison study of two H1N1 influenza vaccines in children
Year Started: 2010
A multi-centre, open-label, clinical, phase 4 trial, following on from a head-to-head comparison study of two H1N1 influenza vaccines in children, to compare firstly, the persistence of antibody against the A/California/7/2009 (H1N1) virus and secondly the immunogenicity and reactogenicity of one dose of a non-adjuvanted trivalent seasonal influenza vaccine, in children who had received a two-dose immunisation regimen of Celvapan or Pandemrix.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Fit and well (finding)
D0011 Swine Flu (Influenza A H1N1) Follow on Vaccine Study
Year Started: 2010
A multi-centre, open-label, clinical, phase 4 trial, following on from a head-to-head comparison study of two H1N1 influenza vaccines in children, to compare firstly, the persistence of antibody against the A/California/7/2009 (H1N1) virus and secondly the immunogenicity and reactogenicity of one dose of a non-adjuvanted trivalent seasonal influenza vaccine, in children who had received a two-dose immunisation regimen of Celvapan or Pandemrix.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Fit and well (finding)
D0015 Improved diagnosis of meningococcal, pneumococcal and group A streptococcal infections
Year Started: 2005
Improved diagnosis of meningococcal, pneumococcal and group A streptococcal infections
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Saliva | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Saliva | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Urine | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Urine | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0016 Server, unusual, or recurrent community acquired infection in children- susceptibility, detection and immune response (CAI)
Year Started: 2006
What makes the bug choose your child, how can we find it and how can we stop it? The study is trying to improve our understanding of why some children get sick when others don’t, even though they must have been exposed to the same bugs. We are also trying to develop ways of finding out what has caused an infection, using ways which don’t rely on finding the bug itself (one example of this would be to test urine for evidence of the bug for example). The other part of the study is to use the information we can get from children who are infected by these bugs to help develop vaccines to increase our ability to prevent infections in the first place.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Urine | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Urine | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Saliva | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Saliva | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0022 Study to evaluate the immunogenicity and safety of a booster dose of Boostrix Polio compared with Repevax, when coadministered with Priorix in 3 and 4-year-old healthy children
Year Started: 2011
Please note, this collection consists of blood clots but it is listed as plasma. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sanofi Pasteur MSD’s dTpa-IPV vaccine (Repevax), when coadministered with GSK Biologicals’ MMR vaccine (Priorix) in 3 and 4-year-old healthy children.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Fit and well (finding)
D0023 Study to demonstrate the efficacy of GlaxoSmithKline Biologicals’ quadrivalent seasonal influenza candidate vaccine GSK2321138A (FLU D-QIV), administered intramuscularly in children 9 to 35 months of age
Year Started: 2011
Please note, this collection consists of blood clots but it is listed as plasma. Study to demonstrate the efficacy of GlaxoSmithKline Biologicals’ quadrivalent seasonal influenza candidate vaccine GSK2321138A (FLU D-QIV), administered intramuscularly in children 9 to 35 months of age.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Fit and well (finding)
D0024 Study to Assess Antibody Persistence and Response to a Third or Fifth Dose of Novartis Meningococcal B Recombinant Vaccine in 4-Year-Old Children Who Previously Participated in Study V72P12E1
Year Started: 2013
Please note, this collection consists of blood clots but it is listed as plasma. A new vaccine has been developed by Novartis Vaccines and Diagnostics S.r.l. (“Novartis Vaccines”) aimed at preventing MenB disease. The vaccine is “investigational”, meaning that it has been approved for use in the study but that it is not licensed for routine use. In 2008-2009 a study of this MenB vaccine, enrolling 1,800 children, was conducted in the UK and other European countries. Of these, 1,510 children participated in a follow-on study, receiving a further dose of MenB at 12, 18, or 24 months of age. In addition 3 control groups received 2 doses of the MenB vaccine, 2 months apart, at 12, 18 or 24 months of age. Children who have completed this study are now being approached to take part in a second ‘follow-on’ study in which the majority of children will receive one further dose of the MenB vaccine at around 4 years of age. The aim of this follow-on study is to assess whether children immunised as infants and/or toddlers with the MenB vaccine have maintained high levels of antibodies against MenB germs until they are around 4 years of age. We would also like to assess how well children respond to a further dose of the MenB vaccine. In addition we will be monitoring the safety of the MenB vaccine.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Fit and well (finding)
D0025 Broader protection against pneumococcal disease: a follow-on study
Year Started: 2010
Please note, this collection consists of blood clots but it is listed as plasma. During the initial study your child received one of 2 pneumococcal vaccines; either the 7-valent pneumococcal vaccine (PCV7) which protects against 7 types of pneumococcal bacteria, or the new 13-valent pneumococcal vaccine (PCV13) protecting against 13 types of pneumococcus which has recently replaced PCV7 in the routine immunisation schedule. The PCV13 vaccine has been shown to produce an immune response against 13 types of pneumococcus and therefore provides a broader level of protection than the PCV7 vaccine. It is now important to determine how well the immune response to the PCV13 vaccine persists throughout childhood. To do this we would like to take a sample of blood from children, who participated in the original study, when they are approximately 3 ½ years of age. We would also like to study the response to a dose of PCV13 vaccine when given to children who were immunised with either PCV7 or PCV13 as an infant.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Chronic multifocal osteomyelitis (disorder)
D0031 Duration of INtravenous antibiOtic therapy for Septic Arthritis or acUte osteomyelitis in a paediatRic population ("Dinosaur" end of study deposit)
Year Started: 2013
These blood samples are from children (1 year old – 16 years old) who were admitted for treatment for suspected or confirmed septic arthritis or osteomyelitis, and enrolled in the Dinosaur study.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Fit and well (finding)
D0032 The Bristol Nasal Colonisation Surveillance Study
Year Started: 2011
The effects of viral upper respiratory tract infections on bacterial colonisation of the nasopharynx in young healthy children attending day care centres. A single centre prospective longitudinal follow up study.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Male
Young child (2 - 6 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
RNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
RNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0034 The effects of live attenuated trivalent intranasal influenza vaccine on nasopharyngeal bacterial colonisation in healthy children aged 2-4 years attending day care centres
Year Started: 2011
The effects of live attenuated trivalent intranasal influenza vaccine on nasopharyngeal bacterial colonisation in healthy children aged 2-4 years attending day care centres. A single centre, randomised intervention study.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Male
Young child (2 - 6 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Fit and well (finding)
D0036 Human responses to candidate pneumococcal vaccines (“PATH longitudinal study”)
Year Started: 2008
Samples were collected as part of the “PATH longitudinal study” from a total of 60 healthy children aged 0-16 years when they were undergoing routine adenoidectomy or adenotonsillectomy surgery.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Young child (2 - 6 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Male
Young child (2 - 6 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Female
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Male
Young child (2 - 6 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Female
Young child (2 - 6 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Not applicable | 26 - 50% |